Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Yulia Litvinova

Dados Biográficos

ID9570326
NOMEYulia Litvinova
PRENOMESYulia
SOBRENOMELitvinova
ASSINATURALITVINOVA Y
AFILIAÇÕESTechnische Universität Berlin
ORCID0000-0002-3786-529X
VERIFICADOSim
TOTAL DE OBRAS3
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR3
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2023
ANO MAIS RECENTE DE PUBLICAÇÃO2026
ÍNDICE H0
  • The role of EU funds in capital investment for health-care

    Open Access•Triin Habicht, Kaija Kasekamp et al.•ARTICLE•Health Policy•2026

    BACKGROUND: Many health systems need substantial capital investment to advance people-centred, integrated care, but public capital budgets are often constrained. Estonia strategically leveraged EU grants to enable provider-network transformation alongside broader service-delivery reforms. REFORM CONTENT: After EU accession, Estonia leveraged EU grants to finance coordinated programmes of investment aligned with national strategies. Across 121 pro…

  • Availability and financing of CAR-T cell therapies

    Open Access•Yulia Litvinova, Sherry Merkur et al.•ARTICLE•Health Policy•2024

    Chimeric antigen receptor T-cell therapies (CAR-T therapies) are a type of advanced therapy medicinal product (ATMP) that belong to a new generation of personalised cancer immunotherapies. This paper compares the approval, availability and financing of CAR-T cell therapies in ten countries. It also examines the implementation of this type of ATMP within the health care system, describing the organizational elements of CAR-T therapy delivery and t…

  • Me, myself, and I

    Open Access•Yulia Litvinova, Rainer Michael Rilke et al.•ARTICLE•Computers in Human Behavior•2023

Sem obras proeminentes nesta página.

  • Me, myself, and I

    Open Access•Yulia Litvinova, Rainer Michael Rilke et al.•ARTICLE•Computers in Human Behavior•2023

  • Availability and financing of CAR-T cell therapies

    Open Access•Yulia Litvinova, Sherry Merkur et al.•ARTICLE•Health Policy•2024

    Chimeric antigen receptor T-cell therapies (CAR-T therapies) are a type of advanced therapy medicinal product (ATMP) that belong to a new generation of personalised cancer immunotherapies. This paper compares the approval, availability and financing of CAR-T cell therapies in ten countries. It also examines the implementation of this type of ATMP within the health care system, describing the organizational elements of CAR-T therapy delivery and t…

  • The role of EU funds in capital investment for health-care

    Open Access•Triin Habicht, Kaija Kasekamp et al.•ARTICLE•Health Policy•2026

    BACKGROUND: Many health systems need substantial capital investment to advance people-centred, integrated care, but public capital budgets are often constrained. Estonia strategically leveraged EU grants to enable provider-network transformation alongside broader service-delivery reforms. REFORM CONTENT: After EU accession, Estonia leveraged EU grants to finance coordinated programmes of investment aligned with national strategies. Across 121 pro…

Aesthetic Perception and Analysis (1 obras) · Biomedical Ethics and Regulation (1 obras) · Biosimilars and Bioanalytical Methods (1 obras) · Business (1 obras) · Capital expenditure (1 obras) · CAR-T cell therapy research (1 obras) · Cognitive psychology (1 obras) · Computer Science (1 obras) · Control reconfiguration (1 obras) · Finance (1 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae